Brief: Cereno Scientific Granted FDA Fast Track For CS1 In PAH Treatment
26/08/2025 10:47
Aug 26 (Reuters) - Cereno Scientific AB CRNOSb.ST: GRANTED FDA FAST TRACK FOR CS1 IN PAH TREATMENT Source text: ID:nWkr91MCdT Further company coverage: [CRNOSb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Cereno Scientific AB
See all newsBrief: Cereno Scientific Expects Up To 15 Activated Sites By 2026 In Epimode Trial
Brief: Cereno Scientific Reports Positive Results From Study
Brief: Cereno Scientific Q2 Net Sales Sek 0
Sweden's Cereno Scientific Q2 net loss widens, hurt by clinical development costs
Brief: Cereno Scientific Q2 Loss After Financial Items SEK 30.5 Mln